Literature DB >> 16985740

Gene therapy for prostate cancer.

S F Shariat, K M Slawin.   

Abstract

Entities:  

Year:  2000        PMID： 16985740      PMCID： PMC1476102     

Source DB:  PubMed          Journal:  Rev Urol        ISSN： 1523-6161


× No keyword cloud information.
  3 in total

1.  Adenovirus-mediated interleukin-12 gene therapy for prostate cancer: suppression of orthotopic tumor growth and pre-established lung metastases in an orthotopic model.

Authors:  Y Nasu; C H Bangma; G W Hull; H M Lee; J Hu; J Wang; M A McCurdy; S Shimura; G Yang; T L Timme; T C Thompson
Journal:  Gene Ther       Date:  1999-03       Impact factor: 5.250

2.  In situ gene therapy for adenocarcinoma of the prostate: a phase I clinical trial.

Authors:  J R Herman; H L Adler; E Aguilar-Cordova; A Rojas-Martinez; S Woo; T L Timme; T M Wheeler; T C Thompson; P T Scardino
Journal:  Hum Gene Ther       Date:  1999-05-01       Impact factor: 5.695

3.  Cooperative therapeutic effects of androgen ablation and adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy in experimental prostate cancer.

Authors:  S J Hall; S E Mutchnik; G Yang; T L Timme; Y Nasu; C H Bangma; S L Woo; M Shaker; T C Thompson
Journal:  Cancer Gene Ther       Date:  1999 Jan-Feb       Impact factor: 5.987
  3 in total
  1 in total

1.  Mesenchymal stem cells modified to express lentivirus TNF-α Tumstatin(45-132) inhibit the growth of prostate cancer.

Authors:  Xu Zhang; Wenrong Xu; Hui Qian; Wei Zhu; Ruiwen Zhang
Journal:  J Cell Mol Med       Date:  2011-02       Impact factor: 5.310
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.